REQUEST A DEMO
Total
USD $0.00
Search more companies

Rubicon Pharmaceuticals SRL (Romania)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Rubicon Pharmaceuticals SRL Profile Updated: August 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Rubicon Pharmaceuticals SRL is an enterprise located in Romania, with the main office in GHIRODA. The enterprise currently operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. It was established on April 20, 2012. It currently has a total number of 19 (2022) employees. From the latest financial highlights, Rubicon Pharmaceuticals SRL reported a net sales revenue increase of 16.15% in 2023. Over the same period, its total assets grew by 33.45%. Rubicon Pharmaceuticals SRL’s net profit margin decreased by 0.83% in 2023.

Headquarters
Strada Lugojului Nr. 134/8
GHIRODA; Timis; Postal Code: 307200

Contact Details: Purchase the Rubicon Pharmaceuticals SRL report to view the information.

Basic Information
Total Employees:
Purchase the Rubicon Pharmaceuticals SRL report to view the information.
Outstanding Shares:
Purchase the Rubicon Pharmaceuticals SRL report to view the information.
Registered Capital:
Purchase the Rubicon Pharmaceuticals SRL report to view the information.
Incorporation Date:
April 20, 2012
Key Executives
Purchase this report to view the information.
Administrator
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Rubicon Pharmaceuticals SRL report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RON. Absolute financial data is included in the purchased report.
Net sales revenue
16.15%
Total operating revenue
16.17%
Operating profit (EBIT)
-2.81%
EBITDA
-0.77%
Net Profit (Loss) for the Period
-2.61%
Total assets
33.45%
Total equity
42.56%
Operating Profit Margin (ROS)
-1.09%
Net Profit Margin
-0.83%
Return on Equity (ROE)
-13.89%
Debt to Equity Ratio
15.59%
Quick Ratio
0.06%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?